Official HCP Homepage | SPINRAZA® (nusinersen) | HCP
Biogen update on European access to Spinraza – TreatSMA
Biogen's blockbuster rare disease drug could be in trouble
These highlights do not include all the information needed to use SPINRAZA® safely and effectively. See full prescribing information for SPINRAZA. SPINRAZA (nusinersen) injection, for intrathecal useInitial U.S. Approval: 2016
Spinraza 12 mg solution for injection - Summary of Product Characteristics (SmPC) - (emc)
Biogen secures extended access agreement for Spinraza
Spinraza 12 mg solution for injection - Summary of Product Characteristics (SmPC) - (emc)
HSE approves Spinraza after lengthy campaign by patients
NHS labels Spinraza deal “one of the most comprehensive in the world”
NHS to use world's most expensive drug to treat spinal muscular atrophy | NHS | The Guardian
5. Spinraza | FiercePharma
Study design | SPINRAZA® (nusinersen) HCP
Hydrocephalus a side effect of Spinraza? - SMA News Today Forums
Biogen provides information on upcoming Spinraza EU label | SMA Europe
Novartis' £1.79M gene therapy Zolgensma scores cost watchdog's backing, threatening Biogen's Spinraza | FiercePharma
Buy Spinraza (Nusinersen) Online • Price & Costs | TheSocialMedwork
Biogen announces new data providing further evidence for SPINRAZA (nusinersen) as a treatment for SMA - Spinal News International
EMA opinion on broad-label approval for Spinraza – TreatSMA
U.S. FDA Approves Biogen's SPINRAZA™ (nusinersen), The First Treatment for Spinal Muscular Atrophy | Biogen
Spinraza - NPS MedicineWise
Roche's low-price Evrysdi will take 'meaningful' SMA share from Biogen's Spinraza: analyst | FiercePharma
Spinraza - FDA prescribing information, side effects and uses
What is Spinraza? Uses, Side Effects & More | TheSocialMedwork
Progress on Early Access Programme of Spinraza – TreatSMA
Drug Puts A $750,000 'Price Tag On Life' | Kaiser Health News
